Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients

被引：3

作者：

Mao, Ziling ^{[1
,2
]}

Baker, Jacqueline Roshelli ^{[1
]}

Takeuchi, Masayoshi ^{[3
]}

Hyogo, Hideyuki ^{[4
,5
]}

Tjonneland, Anne ^{[6
,7
]}

Eriksen, Anne Kirstine ^{[6
]}

Severi, Gianluca ^{[8
,9
]}

Rothwell, Joseph ^{[8
]}

Laouali, Nasser ^{[8
]}

Katzke, Verena ^{[10
]}

Kaaks, Rudolf ^{[10
]}

Schulze, Matthias B. ^{[11
,12
]}

Palli, Domenico ^{[13
]}

Sieri, Sabina ^{[14
]}

de Magistris, Maria Santucci ^{[15
]}

Tumino, Rosario ^{[16
]}

Sacerdote, Carlotta ^{[17
]}

Derksen, Jeroen W. G. ^{[18
]}

Gram, Inger T. ^{[19
]}

Skeie, Guri ^{[19
]}

Sandanger, Torkjel M. ^{[19
]}

Quiros, Jose Ramon ^{[20
]}

Crous-Bou, Marta ^{[21
,22
]}

Sanchez, Maria-Jose ^{[23
,24
,25
,26
]}

Amiano, Pilar ^{[25
,27
,28
]}

Colorado-Yohar, Sandra M. ^{[25
,29
,30
]}

Guevara, Marcela ^{[25
,31
,32
]}

Harlid, Sophia ^{[33
]}

Johansson, Ingegerd ^{[34
]}

Perez-Cornago, Aurora ^{[35
]}

Freisling, Heinz ^{[36
]}

Gunter, Marc ^{[36
]}

Weiderpass, Elisabete ^{[37
]}

Heath, Alicia K. ^{[38
]}

Aglago, Elom ^{[38
]}

Jenab, Mazda ^{[36
]}

Fedirko, Veronika ^{[1
,39
]}

机构：

[1] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA

[2] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA

[3] Kanazawa Med Univ, Med Res Inst, Dept Adv Med, Kanazawa, Ishikawa, Japan

[4] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima, Japan

[5] Lifecare Clin Hiroshima, Hiroshima, Japan

[6] Danish Canc Soc Res Ctr, Diet Canc & Hlth, Copenhagen, Denmark

[7] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark

[8] Univ Paris Saclay, Exposome & Hered Team, Ctr Epidemiol & Populat Hlth, UVSQ,Inserm,U1018, Villejuif, France

[9] G Parenti Univ Florence, Dept Stat, Comp Sci Applicat, Florence, Italy

[10] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

[11] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany

[12] Univ Potsdam, Inst Nutr Sci, Nuthetal, Germany

[13] Inst Canc Res Prevent & Clin Network ISPRO, Canc Risk Factors & Life Style Epidemiol Unit, Florence, Italy

[14] Fdn IRCCS, Epidemiol & Prevent Unit, Ist Nazl Tumori Milano Via Venezian, Milan, Italy

[15] Azienda Osped Univ Federico II, Naples, Italy

[16] AIRE ONLUS, Hyblean Assoc Epidemiol Res, Ragusa, Italy

[17] Citta Salute & Sci Univ Hosp, Unit Canc Epidemiol, Turin, Italy

[18] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands

[19] UiT The Arctic Univ Norway, Dept Community Med, Tromso, Norway

[20] Publ Hlth Directorate, Asturias, Spain

[21] Bellvitge Biomed Res Inst IDIBELL, Unit Nutr & Canc, Canc Epidemiol Res Program, Catalan Inst Oncol, Barcelona, Spain

[22] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA

[23] Escuela Andaluza Salud Publ, Granada, Spain

[24] Inst Invest Biosanitaria Ibs Granada, Granada, Spain

[25] Spanish Consortium Res Epidemiol & Publ Hlth CIBE, Madrid, Spain

[26] Univ Granada, Dept Prevent Med & Publ Hlth, Granada, Spain

[27] Minist Hlth Basque Govt, Sub Directorate Publ Hlth & Addict Gipuzkoa, San Sebastian, Spain

[28] Biodonostia Hlth Res Inst, Epidemiol Chron & Communicable Dis Grp, San Sebastian, Spain

[29] IMIB Arrixaca, Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain

[30] Univ Antioquia, Natl Fac Publ Hlth, Res Grp Demog & Hlth, Medellin, Colombia

[31] Navarra Publ Hlth Inst, Pamplona, Spain

[32] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain

[33] Umea Univ, Dept Radiat Sci, Umea, Sweden

[34] Umea Univ, Dept Odontol, Umea, Sweden

[35] Univ Oxford, Nuffield Dept Populat Hlth, Med Sci Div, Canc Epidemiol Unit, Oxford, England

[36] World Hlth Org IARC WHO, Sect Nutr & Metab, Nutr Epidemiol Grp, Int Agcy Res Canc, Lyon, France

[37] Int Agcy Res Canc IARC WHO, Off Director, Lyon, France

[38] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England

[39] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

来源：

INTERNATIONAL JOURNAL OF CANCER | 2023年 / 152卷 / 11期

关键词：

advanced glycation end products; colorectal cancer; glyceraldehyde-derived advanced glycation end products; mortality; prospective study; TOXIC AGES TAGE; METABOLIC SYNDROME; RECEPTOR; INFLAMMATION; ASSOCIATION; GROWTH; CELLS; COMPLICATIONS; INDIVIDUALS; INVOLVEMENT;

D O I：

10.1002/ijc.34449

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Glyceraldehyde-derived advanced glycation end products (glycer-AGEs) could contribute to colorectal cancer development and progression due to their pro-oxidative and pro-inflammatory properties. However, the association of glycer-AGEs with mortality after colorectal cancer diagnosis has not been previously investigated. Circulating glycer-AGEs were measured by competitive ELISA. Multivariable Cox proportional hazards models were used to calculate hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) for associations of circulating glycer-AGEs concentrations with CRC-specific and all-cause mortality among 1034 colorectal cancer (CRC) cases identified within the European Prospective Investigation into Cancer and Nutrition (EPIC) study between 1993 and 2013. During a mean of 48 months of follow-up, 529 participants died (409 from CRC). Glycer-AGEs were statistically significantly positively associated with CRC-specific (HRQ5 vs Q1 = 1.53, 95% CI: 1.04-2.25, P-trend = .002) and all-cause (HRQ5 vs Q1 = 1.62, 95% CI: 1.16-2.26, P-trend < .001) mortality among individuals with CRC. There was suggestion of a stronger association between glycer-AGEs and CRC-specific mortality among patients with distal colon cancer (per SD increment: HRproximal colon = 1.02, 95% CI: 0.74-1.42; HRdistal colon = 1.51, 95% CI: 1.20-1.91; P-effect modification = .02). The highest HR was observed among CRC cases in the highest body mass index (BMI) and glycer-AGEs category relative to lowest BMI and glycer-AGEs category for both CRC-specific (HR = 1.78, 95% CI: 1.02-3.01) and all-cause mortality (HR = 2.15, 95% CI: 1.33-3.47), although no statistically significant effect modification was observed. Our study found that prediagnostic circulating glycer-AGEs are positively associated with CRC-specific and all-cause mortality among individuals with CRC. Further investigations in other populations and stratifying by tumor location and BMI are warranted.

引用

页码：2257 / 2268

页数：12

共 50 条

[21] THE EFFECT OF PREDILUTION ON-LINE HAEMODIAFILTRATION ON SERUM GLYCERALDEHYDE-DERIVED ADVANCED GLYCATION END-PRODUCTS (TOXIC AGES : TAGE) IN HAEMODIALYSIS PATIENTS
Nakazawa, Ryoichi
Shimizu, Yoichi
Ohkawa, Satoshi
Saito, Yuji
Kashiwabara, Hidehiko
Ono, Mutsumi
Matsugane, Takao
Shibuya, Yasushi
Azuma, Nakanobu
Takeuchi, Masayoshi
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
[22] Glyceraldehyde-derived advanced glycation end products (AGEs). A novel biomarker of postprandial hyperglycaemia in diabetic rats
Kitahara, Y.
Takeuchi, M.
Miura, K.
Mine, T.
Matsui, T.
Yamagishi, S.
CLINICAL AND EXPERIMENTAL MEDICINE, 2008, 8 (03) : 175 - 177
[23] Glyceraldehyde-derived advanced glycation end products as the predictive factor for the disease progression in nonalcoholic steatohepatitis (NASH)
Hyogo, H
Iwamoto, K
Arihiro, K
Shimatani, T
Yokosaki, M
Saeki, T
Nishioka, T
Yamagishi, S
Takeuchi, M
Chayama, K
Tazuma, S
GASTROENTEROLOGY, 2005, 128 (04) : A768 - A768
[24] Dietary Intake of Advanced Glycation End Products (AGEs) and Mortality among Individuals with Colorectal Cancer
Mao, Ziling
Aglago, Elom K.
Zhao, Zhiwei
Schalkwijk, Casper
Jiao, Li
Freisling, Heinz
Weiderpass, Elisabete
Hughes, David J.
Eriksen, Anne Kirstine
Tjonneland, Anne
Severi, Gianluca
Rothwell, Joseph
Boutron-Ruault, Marie-Christine
Katzke, Verena
Kaaks, Rudolf
Schulze, Matthias B.
Birukov, Anna
Krogh, Vittorio
Panico, Salvatore
Tumino, Rosario
Ricceri, Fulvio
Bueno-de-Mesquita, H. Bas
Vermeulen, Roel C. H.
Gram, Inger T.
Skeie, Guri
Sandanger, Torkjel M.
Quiros, J. Ramon
Crous-Bou, Marta
Sanchez, Maria-Jose
Amiano, Pilar
Chirlaque, Maria-Dolores
Barricarte Gurrea, Aurelio
Manjer, Jonas
Johansson, Ingegerd
Perez-Cornago, Aurora
Jenab, Mazda
Fedirko, Veronika
NUTRIENTS, 2021, 13 (12)
[25] Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia
Takeda, Mayu
Ohnuma, Tohru
Takeuchi, Masayoshi
Katsuta, Narimasa
Maeshima, Hitoshi
Takebayashi, Yuto
Higa, Motoyuki
Nakamura, Toru
Nishimon, Shohei
Sannohe, Takahiro
Hotta, Yuri
Hanzawa, Ryo
Higashiyama, Ryoko
Shibata, Nobuto
Gohda, Tomohito
Suzuki, Yusuke
Yamagishi, Sho-ichi
Tomino, Yasuhiko
Arai, Heii
NEUROSCIENCE LETTERS, 2015, 593 : 51 - 55
[26] Glyceraldehyde-derived advanced glycation end-products preferentially induce VEGF expression and reduce GDNF expression in human astrocytes
Miyajima, H
Osanai, M
Chiba, H
Nishikiori, N
Kojima, T
Ohtsuka, K
Sawada, N
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 330 (02) : 361 - 366
[27] Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease
Yamagishi, S
Nakamura, K
Inoue, H
Kikuchi, S
Takeuchi, M
MEDICAL HYPOTHESES, 2005, 64 (06) : 1205 - 1207
[28] The association between glyceraldehyde-derived advanced glycation end-products and colorectal cancer risk: A case-control study nested within the European prospective investigation into cancer and nutrition cohort
Jenab, M.
Kong, S. Y.
Takeuchi, M.
Hyogo, H.
Mckeown-Eyssen, G.
Bruce, W. R.
Romieu, I.
Grp, E. P. I. C.
EUROPEAN JOURNAL OF CANCER, 2015, 51 : S153 - S153
[29] Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation
Dong, Zhenyu
Iwata, Daiju
Kitaichi, Nobuyoshi
Takeuchi, Masayoshi
Sato, Masashi
Endo, Noriko
Iwabuchi, Kazuya
Ando, Ryo
Fukuhara, Junichi
Kinoshita, Satoshi
Lennikov, Anton
Kitamura, Mizuki
Mizuuchi, Kazuomi
Kanda, Atsuhiro
Noda, Kousuke
Namba, Kenichi
Yamagishi, Sho-Ichi
Ohno, Shigeaki
Ishida, Susumu
JOURNAL OF LEUKOCYTE BIOLOGY, 2014, 96 (06) : 1077 - 1085
[30] Pre-diagnostic plasma advanced glycation end-products and soluble receptor for advanced glycation end-products and mortality in colorectal cancer patients
Li, Jinze
Roshelli Baker, Jacqueline
Aglago, Elom K.
Zhao, Zhiwei
Jiao, Li
Freisling, Heinz
Hughes, David J.
Eriksen, Anne Kirstine
Tjonneland, Anne
Severi, Gianluca
Katzke, Verena
Kaaks, Rudolf
Schulze, Matthias B.
Masala, Giovanna
Pala, Valeria
Pasanisi, Fabrizio
Tumino, Rosario
Padroni, Lisa
Vermeulen, Roel C. H.
Gram, Inger T.
Braaten, Tonje
Jakszyn, Paula Gabriela
Sanchez, Maria-Jose
Gomez-Gomez, Jesus-Humberto
Moreno-Iribas, Conchi
Amiano, Pilar
Papier, Keren
Weiderpass, Elisabete
Huybrechts, Inge
Heath, Alicia K.
Schalkwijk, Casper
Jenab, Mazda
Fedirko, Veronika
INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (11) : 1982 - 1995

← 1 2 3 4 5 →